000 | 01046 a2200289 4500 | ||
---|---|---|---|
005 | 20250515025236.0 | ||
264 | 0 | _c20071130 | |
008 | 200711s 0 0 eng d | ||
022 | _a0079-6468 | ||
024 | 7 |
_a10.1016/S0079-6468(05)44404-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAppendino, Giovanni | |
245 | 0 | 0 |
_aClinically useful vanilloid receptor TRPV1 antagonists: just around the corner (or too early to tell)? _h[electronic resource] |
260 |
_bProgress in medicinal chemistry _c2006 |
||
300 |
_a145-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAmides _xchemistry |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPhenylthiourea _xanalogs & derivatives |
650 | 0 | 4 | _aPiperazine |
650 | 0 | 4 |
_aPiperazines _xchemistry |
650 | 0 | 4 |
_aTRPV Cation Channels _xagonists |
700 | 1 | _aSzallasi, Arpad | |
773 | 0 |
_tProgress in medicinal chemistry _gvol. 44 _gp. 145-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0079-6468(05)44404-5 _zAvailable from publisher's website |
999 |
_c16297932 _d16297932 |